BioMed X, a leading pharmaceutical innovation engine, announced on June 23, 2026 the launch of a new global research proposal call focusing on neuroimmunology. Supported by Biogen, the project aims to uncover how neural circuits regulate immune system functions and explore novel therapeutic opportunities for autoimmune diseases.
This call particularly focuses on groundbreaking ideas that cleverly combine neuroscience, immunology, and advanced computational approaches. "The intersection of neuroscience and immunology is one of the most exciting frontiers in biomedical research today," said Dr. Eftekharzadeh of BioMed X. "By integrating cutting-edge experimental platforms with advanced computational tools, we hope to discover new mechanisms that will ultimately benefit patients with autoimmune diseases." Selected teams will gain access to BioMed X's independent research facility in Heidelberg, Germany, and collaborate with global experts on multi-year translational studies.
